Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
46.49
+0.09 (0.19%)
Nov 21, 2024, 2:59 PM EST - Market open
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,276 employees as of December 31, 2023. The number of employees decreased by 35 or -2.67% compared to the previous year.
Employees
1,276
Change (1Y)
-35
Growth (1Y)
-2.67%
Revenue / Employee
$409,675
Profits / Employee
-$438,078
Market Cap
4.29B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| ICU Medical | 14,000 |
| Integer Holdings | 10,500 |
| Haemonetics | 3,657 |
| Oscar Health | 2,400 |
| Alkermes | 2,100 |
| Prestige Consumer Healthcare | 570 |
| BridgeBio Pharma | 556 |
| Axsome Therapeutics | 545 |
RARE News
- 22 hours ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Ultragenyx: Ready For More Growth After Q3 Earnings Beat - Seeking Alpha
- 12 days ago - Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST's 17th Annual Global Science Summit - GlobeNewsWire
- 15 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 6 weeks ago - Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease - GlobeNewsWire
- 2 months ago - Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Ultragenyx to Participate in Investor Conferences in September - GlobeNewsWire